Pharmaceutical Antiretroviral Combinations Comprising Lamivudine, Festinavir and Nevirapine
OwnerGeena Malhotra, Shrinivas Madhukar Purandareinventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to a pharmaceutical antiretroviral composition comprising lamivudine, festinavir and nevirapine, to a process for preparing such a composition and to the use of such a composition for the treatment and/or prophylaxis of diseases caused by retroviruses, especially acquired immune deficiency syndrome or an HIV infection.
Claims30
A pharmaceutical antiretroviral composition comprising lamivudine, festinavir and nevirapine, or a pharmaceutically acceptable salt, solvate, ester, hydrate, enantiomer, derivative, polymorph, prodrug, complex thereof, and optionally one or more pharmaceutically acceptable excipients.
A pharmaceutical antiretroviral composition comprising lamivudine, festinavir and nevirapine in a kit form.
A method for the treatment or prophylaxis of diseases caused by retroviruses, especially acquired immune deficiency syndrome or an HIV infection, which method comprises administering a pharmaceutical antiretroviral composition comprising lamivudine, festinavir and nevirapine to a patient in need thereof.
A method utilizing lamivudine, festinavir and nevirapine in the manufacture of a medicament for the treatment or prophylaxis of diseases caused by retroviruses, especially acquired immune deficiency syndrome or an HIV infection.
(canceled)
(canceled)
Dependencies are inferred from the claim text.